{name}
{subtitle}
A Study to Assess the Efficacy and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
city
~84 mi. (Lóbrega, Spain, +84 more cities)
facility
Site ES34004
drug
gemcitabine, +2 more drugs
drug type
chemotherapy, +1 more type
Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer
city
~91 mi. (El Palmar, Spain, +13 more cities)
facility
Hospital Clínico Universitario Virgen de la Arrixaca
biomarker
ER Negative, +2 more biomarkers
drug
capecitabine, +4 more drugs
drug type
chemotherapy, +1 more type
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
city
~98 mi. (Elche, Spain, +127 more cities)
facility
Hospital General Universitario de Elche
drug
cetuximab, +3 more drugs
drug type
chemotherapy, +1 more type
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
city
~98 mi. (Elche, Spain, +260 more cities)
facility
Hospital General Universitario de Elche; Servicio de Oncologia
biomarker
ERBB2 Amplification, +1 more biomarker
drug type
immunotherapy, +1 more type
Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)
city
~98 mi. (Elche, Spain, +105 more cities)
facility
Hospital General Universitario de Elche ( Site 1155)
drug
bevacizumab, +1 more drug